A randomized, controlled trial of interferon-β-1a (Avonex®) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]

by Genovese, Mark C, Chakravarty, Eliza F, Krishnan, Eswar, Moreland, Larry W
Published 2004

Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid...

by Warren, Marshelle S, Hughes, Steven G, Singleton, Walter, Yamashita, Mason, Genovese, Mark C
Published 2015

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment

by Alten, Rieke, Kaine, Jeffrey, Keystone, Edward, Nash, Peter, Delaet, Ingrid, Genovese, Mark C
Published 2014

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

by Alten, Rieke, Bingham, Clifton O., Cohen, Stanley B., Curtis, Jeffrey R., Kelly, Sheila, Wong, Dennis, Genovese, Mark C.
Published 2016

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial

by Conaghan, Philip G, Emery, Paul, Østergaard, Mikkel, Keystone, Edward C, Genovese, Mark C, Hsia, Elizabeth C, Xu, Weichun, Rahman, Mahboob U
Published 2011

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

by Kirkham, Bruce W, Wasko, Mary Chester, Hsia, Elizabeth C, Fleischmann, Roy M, Genovese, Mark C, Matteson, Eric L, Liu, Hongjuan, Rahman, Mahboob U
Published 2014

Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial

by Strand, Vibeke, Kosinski, Mark, Chen, Chieh-I, Joseph, George, Rendas-Baum, Regina, Graham, Neil M. H., van Hoogstraten, Hubert, Bayliss, Martha, Fan, Chunpeng, Huizinga, Tom, Genovese, Mark C.
Published 2016

Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

by Genovese, Mark C., Smolen, Josef S., Weinblatt, Michael E., Burmester, Gerd R., Meerwein, Sebastian, Camp, Heidi S., Wang, Li, Othman, Ahmed A., Khan, Nasser, Pangan, Aileen L., Jungerwirth, Steven
Published 2016

Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis

by Chakravarty, Eliza F., Martyanov, Viktor, Fiorentino, David, Wood, Tammara A., Haddon, David James, Jarrell, Justin Ansel, Utz, Paul J., Genovese, Mark C., Whitfield, Michael L., Chung, Lorinda
Published 2015

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the r...

by Huizinga, Tom W J, Fleischmann, Roy M, Jasson, Martine, Radin, Allen R, van Adelsberg, Janet, Fiore, Stefano, Huang, Xiaohong, Yancopoulos, George D, Stahl, Neil, Genovese, Mark C
Published 2014

Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study

by Genovese, Mark C, Fleischmann, Roy, Furst, Daniel, Janssen, Namieta, Carter, John, Dasgupta, Bhaskar, Bryson, Judy, Duncan, Benjamin, Zhu, Wei, Pitzalis, Costantino, Durez, Patrick, Kretsos, Kosmas
Published 2014

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis

by Genovese, Mark C., van Vollenhoven, Ronald F., Wilkinson, Bethanie, Wang, Lisy, Zwillich, Samuel H., Gruben, David, Biswas, Pinaki, Riese, Richard, Takiya, Liza, Jones, Thomas V.
Published 2016

Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis

by Emery, Paul, van der Heijde, Désirée, Østergaard, Mikkel, Conaghan, Philip G, Genovese, Mark C, Keystone, Edward C, Fleischmann, Roy, Hsia, Elizabeth C, Xu, Weichun, Xu, Stephen, Rahman, Mahboob U
Published 2011

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

by Keystone, Edward C, Taylor, Peter C, Drescher, Edit, Schlichting, Douglas E, Beattie, Scott D, Berclaz, Pierre-Yves, Lee, Chin H, Fidelus-Gort, Rosanne K, Luchi, Monica E, Rooney, Terence P, Macias, William L, Genovese, Mark C
Published 2015

Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment: Epithelial Expression of Tissue-...

by Kunkel, Eric J., Campbell, James J., Haraldsen, Guttorm, Pan, Junliang, Boisvert, Judie, Roberts, Arthur I., Ebert, Ellen C., Vierra, Mark A., Goodman, Stuart B., Genovese, Mark C., Wardlaw, Andy J., Greenberg, Harry B., Parker, Christina M., Butcher, Eugene C., Andrew, David P., Agace, William W.
Published 2000